In cellular and mouse models of NAFLD, increased expression of xanthine oxidase (XO), a rate-limiting enzyme that catalyzes uric acid production, could very well explain the underlying mechanisms of how NAFLD causes hyperuricemia (16). Here, XDH is linked to metabolic dysfunction-associated steatotic liver disease.